Trial · NCT07906522
Future School of Comprehensive Well-Being
NCT07906522, Not applicable, Active not recruiting, University of Helsinki
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Future School of Comprehensive Well-Being. Trials, record NCT07906522. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906522
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Future School of Comprehensive Well-Being
- NCT number
- NCT07906522
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 1,440 participants, actual
- Lead sponsor
- University of Helsinki
- Conditions
Learning, Comprehensive Wellbeing, Social Wellbeing, Physical Wellbeing, Mental Wellbeing, Pedagogical Practices, General Mental Health and Well-Being, Mental Disorders, Common Mental Disorders (CMD), Sedentary Behavior, Physical Inactivity, Depressive Symptom, Anxiety, Resilience, Psychological
- Interventions
- Comprehensive well-being pedagogy intervention for primary and lower secondary school students
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Study engagement | up to 19 months | Study engagement scale (9 items), which measures energy, dedication, and absorption in studying. Each item is rated on 7-point Likert scale (Totally disagree = 1, Totally agree =7), with higher value indicating stronger engagement. |
| Secondary | Resilience | up to 19 months | Connor-Davidson Resilience Scale (CD-RISC, 10 items). Comprises 25 items, each rated on a 5-point scale (0-4). Range from 0 to 100, with higher scores reflecting greater resilience. |
| Secondary | Anxiety and depression | up to 19 months | Anxiety and depressive symptoms; Revised Child Anxiety and Depression Scale (RCADS, 25 items). The RCADS-25 has 25 items, each rated on a 4-point Likert scale (0 = Never, 1 = Sometimes, 2 = Often, 3 = Always). Therefore, the total raw score can range from 0 to 75 (25 items × 3 points each). Higher scores indicate more symptoms of anxiety or depression. |
| Secondary | Generic well-being | up to 19 months | The World Health Organization-Five Well-Being Index (WHO-5) (5 items). Each item is rated on a 6-point Likert scale. The total raw score range is 0-25; higher scores indicate better well-being. |
| Secondary | Study burnout | up to 19 months | Study burnout scale (7 items). Each item is rated on 7-point Likert scale (Totally disagree = 1, Totally agree =7), with higher scores reflecting higher risk for study burnout. |
| Secondary | Social media addiction | up to 19 months | Bergen Social Media Addiction Scale (BSMAS, 6 items) |
| Secondary | Classroom peer interaction | up to 19 months | The Classroom Peer Context Questionnaire (CPCQ, 20 items). Each item is rated on 7-point Likert scale (Totally disagree = 1, Totally agree =7), with higher value indicating better fit and atmosphere. |
| Secondary | Peer social support | up to 19 months | Peer support scale (10 items). Each item is rated on 7-point Likert scale (Totally disagree = 1, Totally agree =7), with higher scores reflecting greater peer support for studying. |
| Secondary | Empathy towards peers | up to 19 months | Empathy towards peers scale (9 items) |
| Secondary | Teacher social support | up to 19 months | Teacher support scale (11 items). Each item is rated on 7-point Likert scale (Totally disagree = 1, Totally agree =7), with higher scores reflecting greater teacher support. |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906522
GET https://conductscience.org/api/trials/v1/NCT07906522/registered?page=2